Neuphoria Therapeutics
NASDAQ: NEUP
$3.79
+0.08
(+2.05%)
Live
as on
Neuphoria Therapeutics Stock Performance
as on September 19, 2026 at 4:20 am IST
Day's Low
Day's High
$3.71$3.83
2.11%
Downside
1.06%
Upside
52 Week's Low
52 Week's High
$3.19$21.4015.83%
Downside
464.65%
Upside
Neuphoria Therapeutics share price movements today
- Previous Close
- $3.71
- Open
- $3.71
- Volume
- 2.7K
- Market Cap
- $20.4M
- Day's Low - High
- $3.71 - $3.83
- 52 Week Low - High
- $3.19 - $21.40
Neuphoria Therapeutics Historical Returns
- 1 Month Return
- -2.86 %
- 3 Month Return
- -13.23 %
- 1 Year Return
- -64.82 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Neuphoria Therapeutics Stock Fundamentals & Key Indicators
Check Neuphoria Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$20.4M
EPS (TTM)
-4.07
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-62.90%
Neuphoria Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Neuphoria Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Neutral | $20.4M | NA | NA | 0.00% | 0.00% | |
| BUY | $63.1B | -63.24% | -19.81 | -12.57% | 0.00% | |
| BUY | $130.1B | 174.21% | 29.81 | 86.04% | 0.00% | |
| BUY | $79.7B | 21.1% | 18.48 | 84.86% | 0.48% |
Stock Returns calculator for Neuphoria Therapeutics Stock including INR - Dollar returns
The Neuphoria Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Neuphoria Therapeutics investment value today
Current value as on today
₹38,753
Returns
Returns from Neuphoria Therapeutics Stock
Dollar Impact
₹3,099 (+3.1%)
Analyst Recommendation on Neuphoria Therapeutics Stock
Based on 1 analysts
0.00%
Buy
100.00%
Hold
0.00%
Sell
Indian Investors' Interest in Neuphoria Therapeutics Stock
Search interest for Neuphoria Therapeutics Stock has decreased by -87% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Neuphoria Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Neuphoria Therapeutics Annual Profit & Loss
All numbers in Millions USD
Neuphoria Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Neuphoria Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Neuphoria Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 521.1% return, outperforming this stock by 581.6%
NEGATIVE IMPACTPrice Dip
In the last 1 year, NEUP stock has moved down by -60.5%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 1.86M → -505.06K (in $), with an average decrease of 127.1% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 15.0M → -10.47M (in $), with an average decrease of 169.8% per quarter
About Neuphoria Therapeutics
| Organisation | Neuphoria Therapeutics |
| Headquarters | 100 Summit Drive, Burlington, MA, United States, 01803 |
| Industry | Biotechnology |
| CEO | Dr. Spyridon Papapetropoulos M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Neuphoria Therapeutics
Name | Title |
|---|---|
Dr. Spyridon Papapetropoulos M.D., Ph.D. | Interim CEO & Executive Director |
Mr. Timothy M. Cunningham CPA, M.B.A. | Fractional CFO |
Dr. Julie Kerner Ph.D. | Senior Vice President of Business Operations |
Mr. Adrian Hinton BEC, F.C.A. | Financial Controller |
Mr. Rajeev Chandra B.Com., C.A., M.B.A. | Company Secretary |
FAQs
What is Neuphoria Therapeutics share price today?
Neuphoria Therapeutics share price today is $3.79 as on . Neuphoria Therapeutics share today touched a day high of $3.83 and a low of $3.71.
What is the 52 week high and 52 week low for Neuphoria Therapeutics share?
Neuphoria Therapeutics share touched a 52 week high of $21.40 on and a 52 week low of $3.19 on . Neuphoria Therapeutics stock price today i.e. is trending at $3.79,which is 82.29% down from its 52 week high and 18.81% up from its 52 week low.
What is Neuphoria Therapeutics's market capitalisation today?
Neuphoria Therapeutics market capitalisation is $0.00T as on .
How to invest in Neuphoria Therapeutics Stock (NEUP) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Neuphoria Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neuphoria Therapeutics Shares that will get you 0.3958 shares as per Neuphoria Therapeutics share price of $3.79 per share as on September 18, 2026 at 10:50 pm IST.
What is the minimum amount required to buy Neuphoria Therapeutics Stock (NEUP) from India?
Indian investors can start investing in Neuphoria Therapeutics (NEUP) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Neuphoria Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neuphoria Therapeutics share’s latest price of $3.79 as on September 18, 2026 at 10:50 pm IST, you will get 2.6385 shares of Neuphoria Therapeutics. Learn more about
fractional shares .